Hormone substitution--a questionable IGeL indication
Hakimi, R.
MMWFortschrittederMedizin 148(27-28): 16
2006
ISSN/ISBN: 1438-3276 PMID: 16888853 Document Number: 595451
Document emailed within 1 workday
Related Documents
Puls, P.; Brussatis, F.; Staudte, H.W.; Blümlein, H. 1979: A contribution to the differential indication of endoprosthetic knee-joint substitution Zeitschrift für Orthopadie und ihre Grenzgebiete 117(3): 279-286Keller, P.J.; Maurer-Major, E. 1997: Hormone substitution in menopause Praxis 86(38): 1458-1462
Delaloye, J.F. 1995: Hormone substitution following a gynecological cancer Revue Medicale de la Suisse Romande 115(5): 357-359
Breckwoldt, M.; Keck, C. 1994: Hormone substitution beginning when, with what, how long? Geburtshilfe und Frauenheilkunde 54(5): M67-M69
De Boer, H.; van der Veen, E.A. 1996: Growth hormone deficiency and substitution in adults Nederlands Tijdschrift Voor Geneeskunde 140(28): 1441-1445
Rageth, J.C.; Birkhäuser, M.; Castiglione, M. 1998: Hormone substitution therapy after breast cancer--a reevaluation Schweizerische Medizinische Wochenschrift 128(26): 1037-1042
Lauritzen, C. 1990: Colorectal carcinoma and substitution hormone treatment in menopause Zentralblatt für Gynakologie 112(23): 1493-1494
Boissonnas, A. 1994: How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections? Annales de Medecine Interne 145 Suppl. 3: 54-55
Kuhl, H. 1997: Current status: hormone substitution and risk of endometrial carcinoma Zentralblatt für Gynakologie 119(6): 296-297
Jamin, C. 1995: Biological surveillance of hormone substitution: relying on the plasma levels of estradiol or the products used? Journal de Gynecologie Obstetrique et Biologie de la Reproduction 24(5): 467-474
Kattamis, C.A.; Kattamis, A.C. 1995: Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination Seminars in Hematology 32(4): 269-279
Lippert, T.H.; Seeger, H.; Mueck, A.O. 1999: The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause Zentralblatt für Gynakologie 121(10): 467-472
Bocca, G.; van Beek, A.P.; de Bont, E.S.J.M. 2009: Grow hormone deficiency in children after radiation for a brain tumor. Quickly start with substitution Nederlands Tijdschrift Voor Geneeskunde 153(17): 792-793
Bocca, G.; van Beek, A.P.; de Bont, E.S.J.M. 2009: Grow hormone deficiency in children after radiation for a brain tumor. Quickly start with substitution Nederlands Tijdschrift Voor Geneeskunde 153(17): 792-793
Hamerlynck, J.V.; van Leeuwen, F.E. 1996: Long-term postmenopausal hormone substitution and incidence of breast cancer: the Nurses' Health Study Nederlands Tijdschrift Voor Geneeskunde 140(14): 759-761
Van der Mooren, M.J.; Merkus, J.M. 1996: Favorable effects of menopausal hormone substitution therapy on risk factors for ischemic heart disease Nederlands Tijdschrift Voor Geneeskunde 140(25): 1328-1329
Hayashizaki, Y.; Hiraoka, Y.; Endo, Y.; Miyai, K.; Matsubara, K. 1989: Thyroid-stimulating hormone (TSH) deficiency caused by a single base substitution in the CAGYC region of the beta-subunit EMBO Journal 8(8): 2291-2296
Hegedüs, L. 2002: Is there an indication for the treatment of biochemically euthyroid, but clinically hypothyroid individuals with thyroid hormone? Ugeskrift for Laeger 164(51): 6086
Gass, R.; Neff, M. 1995: Prevention of postmenopausal osteoporosis: how effective is transdermal hormone substitution? (Continuous estradiol plus sequential oral norethisterone acetate) Schweizerische Medizinische Wochenschrift 125(34): 1583-1591
Walbert, H. 2013: Which M-IIi or M-IV service can i claim with IGeL? MMW Fortschritte der Medizin 155(10): 10